Pyxis Oncology names Tom Civik CEO and board chairman

PYXS•2026-11-05

Pyxis Oncology appointed Tom Civik CEO and board chairman in September 2026; he had served as interim CEO since February.

1. Leadership changes

Pyxis Oncology appointed Tom Civik CEO and board chairman in September 2026, after he had served as interim CEO since February. Co-founder and founding chairman John Flavin transitioned to lead independent director.

Pyxis Oncology names Tom Civik CEO and board chairman

1. Leadership changes

Related News

Verisk Q3 diluted EPS rises 6% to $1.70

Lightspeed Commerce says lower amortization, higher gross profit narrowed Q2 2027 operating loss

McGraw Hill partners with Anthropic to bring K-12 curriculum to Claude for Teachers

Lincoln International Q3 net income drops 80% to $9.94 million

Teads Holding Co Q3 revenue $235.1 million